Products developed by Theratechnologies target unmet medical needs in commercially attractive specialty markets.

NEWS AND EVENTS

May 27, 2010

FDA Advisory Committee Meeting, Maryland, USA

Endocrinologic and Metabolic Drugs Advisory Committee to review Theratechnologies' New Drug Application ("NDA") for tesamorelin

When? Thursday, May 27, 2010, from 8:00AM to 5:00PM

Where? The Inn and Conference Center
University of Maryland University College
3501 University Blvd. East, Adelphi, MD

Webcast ($)
www.fdalive.com 

FDA Web Site
www.fda.gov/advisorycommittees